CA 125 production in desmoplastic small round cell tumor: Report of a case with elevated serum levels and prominent signet ring morphology

Human Pathology

Volumn 29, Issue 3, 1998, Pages 294-299

  Ordóñez, Nelson G ^a,b   Sahin, Aysegul A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CA 125; Desmoplastic small round cell tumor; Electron microscopy; Immunohistochemistry; Signet ring cells

Indexed keywords

CA 125 ANTIGEN; DESMIN; KERATIN; VIMENTIN;

ADULT; ARTICLE; CARCINOID; CASE REPORT; CELL ULTRASTRUCTURE; CLINICAL FEATURE; DESMOPLASTIC ROUND CELL TUMOR; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY;

EID: 0031939665     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90050-8     Document Type: Article

References (25)

1. Gerald WL, Miller HK, Battifora H, et al: Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol 15:499-513, 1991
2. Ordóñez NG, El-Naggar AK, Ro JY, et al: Intra-abdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. Hum Pathol24:850-865, 1993
3. Hsu S-M, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
4. Kim H, Dorfman RF, Rappaport H: Signet-ring-cell lymphoma: a rare morphologic and functional expression of nodular (follicular) lymphoma. Am J Surg Pathol 2:119-132, 1978
5. Weiss LM, Wood GS, Dorfman RF: T-cell signet-ring-cell lymphoma: a histologic, ultrastructural, and immunohistochemical study of two cases. Am J Surg Pathol 9:273-280, 1985
6. Mendelsohn G: Signet-cell simulating microfollicular adenoma of the thyroid. Am J Surg Pathol 8:705-708, 1984
7. Schroder S, Bocker W: Signet-ring-cell thyroid tumors. Follicle cell tumors with arrest of folliculogenesis. Am J Surg Pathol 9:619-629, 1985
8. Ro JY, El-Naggar A, Ayala AG, et al: Signet-ring-cell carcinoma of the prostate: Electron-microscopic and immunohistochemical studies of eight cases. Am J Surg Pathol 12:453-460, 1988
9. Sheibani K, Battifora H: Signet-ring cell melanoma. A rare morphologic variant of malignant melanoma. Am J Surg Pathol 12:28-34, 1988
10. LiVolsi VA, Brooks JJ, Soslow R, et al: Signet cell melanocytic lesions. Mod Pathol 5:515-520, 1992
11. Kabawat SE, Bast RC, Welch WR, et al: Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol 79:98-104, 1983
12. Davis HM, Zurawski VR, Bast RC, et al: Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res 46:6143-6148, 1987
13. Koelma IA, Nap M, Rodenburg CF, et al: The value of tumor marker CA 125 in surgical pathology. Histopathology 11:287-294, 1987
14. Loy TS, Quesenberry JT, Sharp SC: Distribution of CA 125 in adenocarcinomas: An immunohistochemical study of 481 cases. Am J Clin Pathol 98:175-179, 1992
15. Niloff JM, Klug TL, Schaetzl E, et al: Elevation of serum CA 125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol 148:1057-1058, 1984
16. Lavin PT, Knapp RC, Malkasian G, et al. CA 125 for the monitoring of ovarian carcinoma during primary therapy. Obstet Gynecol 69:223-227, 1987
17. Schwartz PE, Chambers SK, Chambers JT, et al: Circulating tumor markers in the monitoring of gynecologic malignancies. Cancer 60:353-361, 1987
18. Duk JM, Aalders JG, Fleuren GJ, et al: CA 125: A useful marker in endometrial carcinoma. Am J Obstet Gynecol 155:1097-1102, 1986
19. Wick MR, Mills SE, Dehner LP, et al: Serous papillary carcinomas arising from the peritoneum and ovaries. A clinicopathologic and immunohistochemical comparison. Int J Gynecol Pathol 8:179-188, 1989
20. Dietel M, Arps H, Klapdor R, et al: Antigen detection by monoclonal antibodies CA19-9 and CA 125 in normal and tumor tissue and patient's sera. J Cancer Res Clin Oncol 111:257-265, 1986
21. Bollinger DJ, Wick MR, Dehner LP, et al: Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma: A histochemical and immunohistochemical comparison. Am J Surg Pathol 13:659-670, 1989
22. Haga Y, Sakamoto K, Egami H, et al: Clinical significance of CA 125 values in patients with cancers of the digestive system. Am J Med Sci 292:30-34, 1986
23. Haglund C: Tumor marker antigen CA 125 in pancreatic cancer: A comparison with CA19-9 and CEA. Br J Cancer 54:897-901, 1986
24. Lin JY, Angel C, Sickel JE: Meigs' syndrome with elevated serum CA 125. Obstet Gynecol 80:563-566, 1992
25. Timmerman D, Moerman P, Vergote I: Meigs' syndrome with elevated serum CA levels: Two case reports and review of the literature. Gynecol Oncol 59:405-408, 1995